Group/ | NSp-II signal in IIF | Time delay in months | Registered cancer cases | Additional medical history |
---|---|---|---|---|
sample ID | Topography/histology | Diagnosis | ||
Invasive cancer | Â | Â | Â | Â |
PS 1 | Strong | Â | Lung, small cell carcinoma | Â |
PS 2.1 | Strong | 0 | Cervix uteri, carcinoma in situ | Systemic lupus erythematosus |
PS 2.2 | Medium | 26 | Â | Â |
PS 2.3 | Medium | 74 | Â | Â |
PS 2.4 | Medium | 97 | Â | Â |
PS 4 | Medium | Â | Breast, Infiltrating duct carcinoma | Â |
PS 6.1 | Medium | 0 | Lung small cell carcinoma | Arthritis urica/Muscular rheumatism |
PS 6.2 | Strong | 1 | Â | Â |
PS 8.1 | Medium | 0 | Lung, adenocarcinoma | Eye, benign tumor |
PS 8.2 | Medium | 1 | Â | Â |
PS 8.3 | Medium | 4 | Â | Â |
PS 9.1 | Medium | 0 | Ovary, clear cell adenocarcinoma | Peritoneum and lymph node metastasis |
PS 9.2 | Medium | 1 | Â | Â |
PS 9.3 | Medium | 10 | Â | Â |
PS 9.4 | Medium | 18 | Â | Â |
PS 12.1 | Strong | 0 | Brain, unspecified tumor | Sjögren's syndrome/reumatoid arthritis |
PS 12.2 | Medium | 25 | Â | Â |
PS 12.3 | Strong | 51 | Â | Â |
PS 12.4 | Medium | 53 | Â | Â |
PS 13 | Medium | Â | Base of tongue, squamous cell carcinoma | Carrier of Human T-lymphotrophic virus-1/Reactive arthritis |
PS 15 | Strong | Â | Esophagus, Squamous cell carcinoma | Rheumatoid arthritis |
PS 16 | Medium | Â | Breast, infiltrating duct carcinoma | Bone or bone marrow, metastasis /Lymph node malignant tumor |
PS 17.1 | Medium | 0 | Breast, infiltrating duct carcinoma | Septicaemia |
PS 17.2 | Strong | 14 | Â | Â |
PS 17.3 | Medium | 59 | Â | Â |
PS 18 | Medium | Â | Unknown site, adenocarcinoma | Lung, malignant tumor |
PS 23 | Strong | Â | Base of tongue, squamous cell carcinoma | Oropharynx, malignant tumor |
PS 27 | Strong | Â | Lymph node, diffuse large cell lymphoma | Â |
Benign tumor | Â | Â | Â | Â |
PS 3 | Weak | Â | Â | Liver transplantation/Face, benign tumor |
PS 19 | Weak |  |  | Skin, benign tumor/Sjögren's syndrome |
PS 21 | Medium | Â | Â | Breast, benign cystic tumor |
PS 24 | Strong | Â | Â | Neoplasia-associated polyneuropathy |
PS 25 | Weak | Â | Â | Breast, benign tumor |
No neoplasia | Â | Â | Â | Â |
PS 5 | Strong | Â | Â | Septicaemia |
PS 7 | Weak | Â | Â | Â |
PS 10 | Weak | Â | Â | Â |
PS 11 | Strong |  |  | Parkinson’s disease |
PS 14 | Medium | Â | Â | Â |
PS 20 | Medium | Â | Â | Â |
PS 22 | Weak | Â | Â | Â |
PS 26 | Strong | Â | Â | Â |
PS 28 | Medium | Â | Â | Â |